Speaker illustration

Doctor Gabriele Giacomo Schiattarella

Federico II University Hospital, Napoly (Italy)

Member of:

Heart Failure Association

Gabriele Schiattarella is a cardiologist-scientist whose research focuses on molecular mechanisms of remodeling in the disease-stressed myocardium. He received his MD in 2009 from the University Federico II of Naples (Italy). After completing a fellowship in Cardiology at the same university (2015) and matriculating in a PhD program in Experimental Medicine, he moved to University of Texas Southwestern Medical Center in Dallas, Texas, USA where he completed his PhD program and currently serve as researcher. Gabriele’s background is in medicine, experimental cardiology and cellular/molecular biology, with specific training and expertise in murine models of cardiovascular disease and preclinical assessment of cardiovascular function. His research interests include molecular mechanisms of cardiac hypertrophy and heart failure (HFpEF and HFrEF); mitochondrial dysfunction, reactive oxygen species production and nitrosative stress in cardiomyocytes as well as regulation of protein quality

The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Topic: Drugs, Drug Targets

Session type: Symposium

Thumbnail

Chronic heart failure - epidemiology, prognosis, outcome 7

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Valvular heart disease

Event: Heart Failure 2023

Topic: Valvular Heart Disease

Session type: Moderated ePosters

Thumbnail

Multi-omics for personalised medicine

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Topic: Cardiomyopathies

Session type: Symposium

Thumbnail

Pathomechanisms of heart failure with preserved ejection fraction

Event: ESC Congress 2022

Topic: Heart Failure

Session type: Moderated ePosters

Thumbnail

Omics in heart failure: from biomarker to new therapeutic targets

Event: Heart Failure 2022

Topic: Genetics, Epigenetics, ncRNA

Session type: Symposium

Thumbnail